In particular, different studies reported that IL-33 and its receptor ST2 play a critical role in the pathogenesis of different types of cancers, including breast cancer, hepatocellular carcinoma, and colorectal cancer (CRC)31–34. Here, IL1RL1 is linked to hepatocellular carcinoma.